Chiropractors in Selah, WA Accepting Medicare

5 Chiropractors found. Showing 1 - 5

Selah Family Chiropractic P.s. Chiropractor Medicare: Medicare Enrolled Practice Location: 318 S 1st St, Selah, WA 98942 Phone: 509-697-4123    Fax: 509-697-4423

Tony Garent, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 9 E 1st Ave Ste 1, Selah, WA 98942 Phone: 509-697-4838    Fax: 509-697-6132

Dr. David Lee Lemmon, D.C Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 318 S 1st Street, Selah, WA 98942 Phone: 509-697-4123    Fax: 509-697-4423

Tony Garent Chiropractic Clinic P.l.l.c. Chiropractor Medicare: Medicare Enrolled Practice Location: 9 E 1st Ave Ste 1, Selah, WA 98942 Phone: 509-697-4838    Fax: 509-697-6132

Warninger Chiropractic Clinic - Selah Office Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 9 E 1st Ave, Suite 1, Selah, WA 98942 Phone: 509-697-4838

News Archive

ESHRE study shows advantages of CGH technique in IVF procedure

Two women taking part in the world's first controlled study of a comprehensive genetic screening test before IVF have given birth to healthy babies. The babies, twin girls born in Germany in June and a singleton boy born in Italy in September, are the first deliveries in a pilot study of comparative genomic hybridisation (CGH) by microarray, a new method of screening oocytes for IVF for a full range of chromosomal disorders.

MiMedx Group reports record revenue in third quarter 2013

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter ended September 30, 2013.

Gene technology can be potential game-changer for agriculture

Consumers will soon be eating gene-edited foods that have added nutrients, potatoes that do not turn brown, and mushrooms with a longer shelf life, scientists at The University of Queensland predict.

Pfizer to support immatics' IMA901 Phase III trial in advanced renal cell carcinoma

immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, today announced that Pfizer has agreed to support its pivotal Phase III trial with IMA901, its therapeutic cancer vaccine for advanced renal cell carcinoma.

$15 million federal funds for new cancer research program

As a result of C3: Colorectal Cancer Coalition's advocacy efforts, $15 million for a new peer reviewed cancer research program is included in the final Fiscal Year 2010 Defense Appropriations Bill.

Read more Medical News

› Verified 5 days ago